[Interleukin-10 receptor gene mutations induced very early onset inflammatory bowel disease in 6 infants]

F P Wang1, X Ma, D Zhu

  • 1Department of Gastroenterology, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing 100020, China.

Insights

Very early onset inflammatory bowel disease (VEO-IBD) in infants is linked to interleukin-10 receptor alpha subunit (IL-10RA) gene mutations. These mutations often cause severe symptoms and varied treatment responses.

Area of Science:

  • Pediatric Gastroenterology
  • Human Genetics
  • Immunology

Background:

  • Very early onset inflammatory bowel disease (VEO-IBD) presents a significant clinical challenge.
  • Understanding the genetic underpinnings of VEO-IBD is crucial for diagnosis and management.
  • Interleukin-10 receptor alpha subunit (IL-10RA) plays a role in immune regulation.

Purpose of the Study:

  • To investigate the clinical manifestations of VEO-IBD in infants.
  • To identify mutations in the IL-10RA gene in infants diagnosed with VEO-IBD.
  • To correlate IL-10RA mutations with clinical phenotypes and treatment outcomes.

Main Methods:

  • Retrospective review of clinical data from six infants with VEO-IBD.
  • Analysis of symptoms, laboratory findings, colonoscopy, and pathology results.
  • Genetic sequencing of the IL-10RA gene in all affected infants.

Main Results:

  • All six infants presented with persistent diarrhea and fever within the first month of life.
  • Common co-occurring symptoms included anemia, oral/perianal lesions, and growth retardation.
  • IL-10RA gene mutations (homozygous and heterozygous) were identified in all patients, with c.301C>T and c.537G>A being frequent.
  • Treatment responses were variable, with some improvement, worsening, and fatalities.

Conclusions:

  • VEO-IBD is strongly associated with IL-10RA gene mutations.
  • Patients often exhibit severe intestinal and extra-intestinal symptoms.
  • Genetic analysis of IL-10RA is important for diagnosing VEO-IBD.
  • Treatment outcomes for VEO-IBD associated with IL-10RA mutations can be unpredictable.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
991
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
523
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
610
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
742
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.3K